Tesla (NASDAQ: TSLA) is facing mounting challenges, with its stock plunging 50% from post-Trump highs. Investor concerns are fueled by Elon Musk’s involvement with Dogecoin (DOGE), slowing EV sales, and dealership protests. Now, the automaker warns that reciprocal tariffs could further impact its global competitiveness.
In a letter to U.S. Trade Representative Ambassador Jamieson Greer dated March 11, 2025, Tesla highlighted the risks of retaliatory tariffs against U.S. trade actions. The company noted that past tariffs had already increased production costs and hurt U.S. manufacturers exporting overseas. Tesla urged policymakers to consider the broader implications of trade policies on domestic businesses.
Tesla also pointed to weaknesses in the U.S. supply chain, particularly in EV components and lithium-ion batteries. While efforts have been made to localize production, certain parts remain difficult or impossible to source domestically. The automaker emphasized that trade strategies should account for these limitations to avoid disruptions.
Additionally, Tesla recommended phased implementation of any new trade measures. This would allow U.S. companies time to adjust, secure supply chains, and ensure compliance with evolving regulations.
With demand softening and geopolitical risks rising, Tesla’s concerns underscore the growing challenges in the EV industry. Investors will be watching closely as trade policies evolve and impact the company’s global operations.


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Washington Post Publisher Will Lewis Steps Down After Layoffs
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 



